Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
PLBY Group Announces Closing of Public Offering of Common Stock
-
Ocugen, Inc. (OCGN) PT Lowered to $4.50 at Chardan Capital Markets
-
PLBY Group (PLBY) Prices 4.72M Share Upsized Common Offering at $46/Sh
-
PLBY Group Announces Upsize and Pricing of Public Offering of Common Stock
-
PDS Biotechnology Corp (PDSB) PT Raised to $15 at Chardan Capital Markets
-
SPK Acquisition Corp. (SPK) Prices 5M Unit IPO at $10/Unit
-
SPK Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
-
PLBY Group (PLBY) Announced Proposed Offering of 4M Shares
-
PLBY Group Announces Proposed Public Offering of Common Stock
-
PLBY Group (PLBY) Files to Offer 4M Shares of Common Stock
-
Form S-1/A Chardan NexTech Acquisit
-
Form PREM14A Chardan Healthcare Acqui For: Jun 03
-
Chardan Capital Markets Assumes Axcella Health Inc. (AXLA) at Buy
-
Form DEFA14A Chardan Healthcare Acqui
-
Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer
-
Provention Bio Inc. (PRVB) PT Lowered to $22.50 at Chardan Capital Markets Following FDA AdComm Vote
-
Form 10-Q Chardan Healthcare Acqui For: Mar 31
-
Mountain Crest Acquisition Corp. III Announces Closing of $50 Million Initial Public Offering
-
PDS Biotechnology Corp (PDSB) PT Raised to $11 at Chardan Capital Markets
-
Small-Cap & Penny Stocks To Watch In May Hitting It Big In 2021
-
Iovanace Biotherapeutics (IOVA) PT Lowered to $51 at Chardan Capital Markets on BLA Delay
-
IPO for SPAC Mountain Crest Acquisition Corp. III (MCAE) Opens Flat at $10
-
Mountain Crest Acquisition Corp. III (MCAE) Prices 5M Unit IPO at $10/Unit
-
Mountain Crest Acquisition Corp. III Announces Pricing of $50 Million Initial Public Offering
-
Form NT 10-Q Chardan Healthcare Acqui For: Mar 31
-
AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
-
Former Penny Stocks To Watch Making Their Mark In 2021
-
Form SC 13G Chardan Healthcare Acqui Filed by: CITADEL ADVISORS LLC
-
Best Penny Stocks To Buy Right Now? 3 For Your May 2021 Watch List
-
Chardan Acts as Exclusive Placement Agent in Forge Biologics' $120 Million Series B Financing
-
Chardan Capital Markets Downgrades Adverum Biotechnologies (ADVM) to Neutral
-
Forge Biologics Announces Closing of $120 Million Series B Financing
-
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
UPDATE: Chardan Capital Starts Achilles Therapeutics (ACHL) at Buy
-
Forge Biologics to Present at Chardan’s 5th Annual Genetic Medicines Manufacturing Summit
-
NeuBase Therapeutics (NBSE) Prices $40 Million Public Offering of Common Stock at $5/sh
-
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock
-
NeuBase Therapeutics (NBSE) Announces Proposed Public Offering of Common Stock
-
Freeline to Participate in Upcoming Investor Conferences in April and May 2021
-
Freeline to Participate in Upcoming Investor Conferences in April and May 2021
-
NeuBase Therapeutics Announces Proposed Public Offering of Common Stock
-
Mustang Bio to Participate in Chardan’s 5th Annual Genetic Medicines Manufacturing Summit
-
Mustang Bio to Participate in Chardan’s 5th Annual Genetic Medicines Manufacturing Summit
-
REGENXBIO To Present at the Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
Emergent BioSolutions (EBS) Sinks as FDA Requests Pause of Further Production of J&J's (JNJ) COVID-19 Vaccine
-
4D Pharma PLC (LBPS) Named Top Pick at Chardan Capital Markets
-
Nocturne Acquisition Corporation Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering

